News

Media

Conferences

Journals

Events

Resources

Center on Health Equity and Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Academia Employers Health System Payers Providers

Center on Health Equity and Access Clinical Health Care Cost Health Care Delivery Insurance Policy Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Miller PD, Pannacciulli N, Brown JP, et al. Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab. 2016, 101(8):3163-3170. doi: 10.1210/jc.2016-1801.

home / authors / miller-pd-pannacciulli-n-brown-jp-et-al-denosumab-or-zoledronic-acid-in-postmenopausal-women-with-osteoporosis-previously-treated-with-oral-bisphosphonates-j-clin-endocrinol-metab-2016

Articles

Study Summary: Switching From Oral Bisphosphonates to Denosumab or Zoledronic Acid in Women With Postmenopausal Osteoporosis

Read More

Editorial Staff

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences
AJMC®
All rights reserved.